Product Description
Overall, the global cannulated screw market was valued at $538.6 million in 2021. This is expected to increase over the forecast period at a CAGR of 3.1% to reach $665.8 million.
The full report suite on the global market for cannulated screws includes stainless steel and titanium screws, as well as a unit analysis of small, medium and large screws.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
In 2021, the procedure volume for the cannulated screw market increased after a down year in 2020 due to the COVID-19 pandemic. However, the procedure volume did not surpass pre-pandemic levels until the beginning of 2022. It is expected that the number of procedures performed in this market will grow in the low-single-digit range over the forecast period.
GLOBAL CANNULATED SCREWS MARKET TRENDS
The cannulated screw market is characterized by a shift from stainless steel to titanium screws. This can be attributed to the superior characteristics of titanium products. The shift will also have a positive effect on market growth, since the ASP of titanium screws is higher than that of stainless steel screws.
GLOBAL CANNULATED SCREWS MARKET SHARE INSIGHTS
Overall, within the global cannulated screws market there are three dominant competitors: DePuy Synthes, Stryker, and Zimmer Biomet.
DePuy Synthes commanded a dominant share in the global cannulated screw market, controlling nearly half of the entire market. DePuy Synthes benefitted from its strong share in the plate and screw market, which provides a synergistic effect with the company’s cannulated screw product line.
GLOBAL CANNULATED SCREWS MARKET SEGMENTATION SUMMARY
- Stainless Steel Screws
- Titanium Screws
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data. Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
